Nobilis IB Primo QX


avian infectious bronchitis virus strain D388

This medicine is authorised for use in the European Union.


Nobilis IB Primo QX is a veterinary vaccine used to protect chickens against viral infectious bronchitis caused by strains of infectious bronchitis virus known as QX-like variants, such as strain D388.

Nobilis IB Primo QX contains live attenuated (weakened) avian infectious bronchitis virus strain D388 as the active substance.

This EPAR was last updated on 26/04/2021

Authorisation details

Product details
Nobilis IB Primo QX
Agency product number
Active substance
live avian infectious bronchitis virus, strain D388
International non-proprietary name (INN) or common name
avian infectious bronchitis virus strain D388
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Intervet International B.V.
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

20/01/2020 Nobilis IB Primo QX - EMEA/V/C/002802 - II/0009/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Live viral vaccines
  • Domestic fowl

Therapeutic indication

For active immunisation of chickens in order to reduce respiratory signs of avian infectious bronchitis caused by QX-like variants of infectious bronchitis virus.

Assessment history

How useful was this page?

Add your rating